创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

王晋苏, 董婧雯, 黄莹, 范一诺, 张琦岩, 周占威, 孙敏捷. 免疫佐剂及自佐剂递送系统研究进展[J]. 药学进展, 2024, 48(6): 421-436. DOI: 10.20053/j.issn1001-5094.2024.06.004
引用本文: 王晋苏, 董婧雯, 黄莹, 范一诺, 张琦岩, 周占威, 孙敏捷. 免疫佐剂及自佐剂递送系统研究进展[J]. 药学进展, 2024, 48(6): 421-436. DOI: 10.20053/j.issn1001-5094.2024.06.004
WANG Jinsu, DONG Jingwen, HUANG Ying, FAN Yinuo, ZHANG Qiyan, ZHOU Zhanwei, SUN Minjie. Advances in the Study of Immune Adjuvants and Their Delivery Systems[J]. Progress in Pharmaceutical Sciences, 2024, 48(6): 421-436. DOI: 10.20053/j.issn1001-5094.2024.06.004
Citation: WANG Jinsu, DONG Jingwen, HUANG Ying, FAN Yinuo, ZHANG Qiyan, ZHOU Zhanwei, SUN Minjie. Advances in the Study of Immune Adjuvants and Their Delivery Systems[J]. Progress in Pharmaceutical Sciences, 2024, 48(6): 421-436. DOI: 10.20053/j.issn1001-5094.2024.06.004

免疫佐剂及自佐剂递送系统研究进展

Advances in the Study of Immune Adjuvants and Their Delivery Systems

  • 摘要: 佐剂是防治疾病疫苗的重要组分,可增强机体对抗原的特异性免疫应答,显著提高免疫反应的强度、广度和持久性,在传染病防治及肿瘤治疗方面起重要作用。目前基于免疫学与药剂学的发展,传统佐剂暴露出生物毒性强、系统暴露量高及免疫刺激活性机制不明等问题。开发免疫佐剂递送系统正成为生物制品免疫治疗的研究热点。简介已批准上市佐剂的组成与免疫激活机制,分析具备佐剂效应的疫苗递送系统的开发优势,重点综述基于脂质体、病毒样颗粒、有机合成材料、天然生物材料以及无机纳米材料的新型佐剂平台的研究进展,以期为开发安全、有效的新型疫苗佐剂材料和佐剂平台提供参考。

     

    Abstract: As important components of vaccines against diseases, adjuvants can enhance the human body's specific immune response to antigens and significantly increase the strength, breadth and durability of the immune response, thus playing an important role in the prevention and treatment of infectious diseases and tumors. With the development of immunology and pharmacology, traditional adjuvants have been exposed to such problems as biotoxicity, high systemic exposure and unknown mechanism of immunostimulatory activity. Thus, the development of immune adjuvant delivery system has become a research hotspot in biologic immunotherapy. Herein, we summarize the composition and immune activation mechanism of approved adjuvants, analyse and discuss the advantages of vaccine delivery systems with adjuvant effects, and focus on the progress of novel adjuvant platforms based on liposomes, virus-like particles, organic synthetic materials, natural biomaterials and inorganic nanomaterials, in order to provide some reference for the development of safe and effective novel vaccine adjuvant materials and adjuvant platforms.

     

/

返回文章
返回